Literature DB >> 1567206

Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P450IA2.

R W Lambrecht1, P R Sinclair, N Gorman, J F Sinclair.   

Abstract

Previous work suggested that the oxidation of uroporphyrinogen to uroporphyrin is catalyzed by cytochrome P450IA2. Here we determined whether purified reconstituted mouse P450IA1 and IA2 oxidize uroporphyrinogen. Cytochromes P450IA1 and IA2 were purified from hepatic microsomes from 3-methylcholanthrene (MC)-treated C57BL/6 mice, using a combination of affinity chromatography and high performance liquid chromatography. Reconstituted P450IA1 was more active than P450IA2 in catalyzing ethoxyresorufin-O-deethylase (EROD) activity, whereas P450IA2 was more active than P450IA1 in catalyzing uroporphyrinogen oxidation (UROX). Both reactions required NADPH, NADPH-cytochrome P450 reductase, and either P450IA1 or IA2. Ketoconazole competitively inhibited both EROD and UROX activities, in microsomes from MC-treated mice. Ketoconazole also inhibited UROX catalyzed by reconstituted P450IA2. In contrast, ketoconazole did not inhibit UROX catalyzed by xanthine oxidase in the presence of iron-EDTA. Superoxide dismutase, catalase, and mannitol inhibited UROX catalyzed by xanthine oxidase/iron-EDTA, but did not affect UROX catalyzed by either microsomes or reconstituted P450IA2. These results suggest that UROX catalyzed by P450IA2 in microsomes and reconstituted systems does not involve free reactive oxygen species. Two known substrates of cytochrome P450IA2, 2-amino-3,4-dimethylimidazole[4,5-f]quinoline and phenacetin, were shown to inhibit the microsomal UROX reaction, suggesting that uroporphyrinogen binds to a substrate-binding site on the cytochrome P450.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567206     DOI: 10.1016/0003-9861(92)90717-b

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.

Authors:  P R Sinclair; N Gorman; T Dalton; H S Walton; W J Bement; J F Sinclair; A G Smith; D W Nebert
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

2.  Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.

Authors:  Norman G Egger; Douglas E Goeger; Deborah A Payne; Emil P Miskovsky; Steven A Weinman; Karl E Anderson
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

Review 3.  Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.

Authors:  Shu-Feng Zhou; Li-Ping Yang; Zhi-Wei Zhou; Ya-He Liu; Eli Chan
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

4.  Synergistic effect of 2,2',4,4',5,5'-hexachlorobiphenyl and 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic porphyrin levels in the rat.

Authors:  A P van Birgelen; K M Fase; J van der Kolk; H Poiger; A Brouwer; W Seinen; M van den Berg
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

5.  Ancestral Sequence Reconstruction of a Cytochrome P450 Family Involved in Chemical Defense Reveals the Functional Evolution of a Promiscuous, Xenobiotic-Metabolizing Enzyme in Vertebrates.

Authors:  Kurt L Harris; Raine E S Thomson; Yosephine Gumulya; Gabriel Foley; Saskya E Carrera-Pacheco; Parnayan Syed; Tomasz Janosik; Ann-Sofie Sandinge; Shalini Andersson; Ulrik Jurva; Mikael Bodén; Elizabeth M J Gillam
Journal:  Mol Biol Evol       Date:  2022-06-02       Impact factor: 8.800

Review 6.  Uroporphyrinogen decarboxylase.

Authors:  G H Elder; A G Roberts
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

Review 7.  Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2.

Authors:  K Brøsen
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

8.  Inhibition of ethoxyresorufin-O-deethylase (EROD) activity in mixtures of 2,3,7,8-tetrachlorodibenzo-p-dioxin and polychlorinated biphenyls : EROD acitivity as biomarker in TCDD and PCB risk assessment.

Authors:  M Tysklind; A B Bosveld; P Andersson; E Verhallen; T Sinnige; W Seinen; C Rappe; M van den Berg
Journal:  Environ Sci Pollut Res Int       Date:  1995-07       Impact factor: 4.223

9.  Genetic variation of iron-induced uroporphyria in mice.

Authors:  A G Smith; J E Francis
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

10.  Cytochrome P450 1D1: a novel CYP1A-related gene that is not transcriptionally activated by PCB126 or TCDD.

Authors:  J V Goldstone; M E Jönsson; L Behrendt; B R Woodin; M J Jenny; D R Nelson; J J Stegeman
Journal:  Arch Biochem Biophys       Date:  2008-12-10       Impact factor: 4.013

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.